Keyword Pages
juvenile dermatomyositis 367
panniculitis 367
pediatric 367
subcutaneous tissue 367
corticosteroid 273
intraarticular injection 273
knee osteoarthritis 273, 335
platelet rich plasma 273
collagen-induced arthritis 309
rheumatoid arthritis 309, 328, 316, 251
sorafenib 309
dermal fibrosis 288
paricalcitol 288
scleroderma 288
wnt/β-catenin pathway 288
children 282
concomitant 282
familial mediterranean fever 282
severity 282
balance disorder 328
foot deformity 328
functional status 328
exercise 295
physical function 295
physical therapy 295
osteoarthritis 295
clinically amyopathic dermatomyositis 376
dermatomyositis 376
diffuse alveolar damage 376
organizing pneumonia 376
polymyositis 376
interstitial lung diseases 322
pulmonary hypertension 322
systemic sclerosis 322, 316
methotrexate 302
mizoribine 302
polymyalgia rheumatica 302
prednisone 302
fatigue 316
quality of life 316
isokinetic muscle performance 335
kinesiology taping 335
western ontario and mcmaster osteoarthritis index 335
intestinal perforation 372
pneumatosis intestinalis 372
tocilizumab 372
juvenile localized scleroderma 344
juvenile systemic sclerosis 344
raynaud’s phenomenon 344
skin stiffening 344
behçet’s disease 352
hla-b*51 352
mica 352
mica*006 352
mica*009 352
disease modifying anti-rheumatic drugs 251
management 251
treatment recommendations 251
turkish league against rheumatism 251
discoid lupus 358
systemic lupus erythematosus 358
transforming growth factor-beta 1 358